Shenzhen - Delayed Quote CNY

Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ)

134.61 +0.40 (+0.30%)

At close: October 30 at 3:04:03 PM GMT+8

Chart Range Bar

Loading chart for 002821.SZ

Previous Close 134.21
Open 132.51
Bid 134.61 x --
Ask 134.62 x --
Day's Range 127.65 - 142.00
52 Week Range 88.46 - 200.00
Volume 8,860,700
Avg. Volume 10,448,183
Market Cap (intraday) 48.722B
Beta (5Y Monthly) 0.19
PE Ratio (TTM) 40.30
EPS (TTM) 3.34
Earnings Date (est.) --
Forward Dividend & Yield 1.30 (0.97%)
Ex-Dividend Date Jun 26, 2026
1y Target Est 192.39

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.

www.asymchem.com.cn

10,617

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002821.SZ

46.11%

SSE Composite Index (000001.SS)

9.32%

1-Year Return

002821.SZ

32.43%

SSE Composite Index (000001.SS)

9.73%

3-Year Return

002821.SZ

13.84%

SSE Composite Index (000001.SS)

19.11%

5-Year Return

002821.SZ

49.38%

SSE Composite Index (000001.SS)

1.46%

Earnings Per Share

No Earnings Per Share available for this ticker

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q3 FY26

Revenue 1.79B

Earnings --

Profit Margin 0.00%

FY25

FY26

500M

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

Analyst Price Targets

168.00

192.39 Average

134.61 Current

233.11 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

15.93%
Return on Assets (ttm)

4.05%
Return on Equity (ttm)

6.70%
Revenue (ttm)

7.44B
Net Income Avi to Common (ttm)

1.18B
Diluted EPS (ttm)

3.34

Balance Sheet and Cash Flow

Total Cash (mrq)

6.68B
Total Debt/Equity (mrq)

3.87%
Levered Free Cash Flow (ttm)

-1.25B

300347.SZ Hangzhou Tigermed Consulting Co., Ltd

49.67 +3.07%

300122.SZ Chongqing Zhifei Biological Products Co., Ltd.

13.49 +4.74%

000661.SZ Changchun High-Tech Industry (Group) Co., Ltd.

69.69 -2.30%

300015.SZ Aier Eye Hospital Group Co., Ltd.

8.52 +3.65%

603259.SS WuXi AppTec Co., Ltd.

142.01 -0.62%

U.S. markets closed

Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ)

-7.94%

-28.63%

7.21%

44.85%

31.29%

-52.67%

608.47%

Asymchem Laboratories (Tianjin) Co., Ltd. Overview Biotechnology / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch